Outcome and Treatment of Elderly Patients with ANCA-Associated Vasculitis

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F15%3A10296038" target="_blank" >RIV/00216208:11110/15:10296038 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064165:_____/15:10296038

Výsledek na webu

<a href="http://dx.doi.org/10.2215/CJN.00480115" target="_blank" >http://dx.doi.org/10.2215/CJN.00480115</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.2215/CJN.00480115" target="_blank" >10.2215/CJN.00480115</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Outcome and Treatment of Elderly Patients with ANCA-Associated Vasculitis

Popis výsledku v původním jazyce

Background and objectives ANCA-associated vasculitis is commonly found in elderly patients, but there are few data concerning outcome and treatment in the highest age groups. Design, setting, participants, & measurements Consecutive patients (N=151) presenting between 1997 and 2009 were retrospectively included from local registries in six centers in Sweden, the United Kingdom, and the Czech Republic if diagnosed with microscopic polyangiitis or granulomatosis with polyangiitis at age years during the study period. Patients were followed until 2 years from diagnosis or death. Data on survival and renal function were analyzed with respect to age, sex, ANCA specificity, renal function, C-reactive protein, comorbidities, and Birmingham Vasculitis ActivityScore at diagnosis as well as treatment during the first month. Results Median follow-up was 730 days (interquartile range, 244-730). Overall 1-year survival was 71.5% and 2-year survival was 64.6%. Older age; higher creatinine, and lowe

Název v anglickém jazyce

Outcome and Treatment of Elderly Patients with ANCA-Associated Vasculitis

Popis výsledku anglicky

Background and objectives ANCA-associated vasculitis is commonly found in elderly patients, but there are few data concerning outcome and treatment in the highest age groups. Design, setting, participants, & measurements Consecutive patients (N=151) presenting between 1997 and 2009 were retrospectively included from local registries in six centers in Sweden, the United Kingdom, and the Czech Republic if diagnosed with microscopic polyangiitis or granulomatosis with polyangiitis at age years during the study period. Patients were followed until 2 years from diagnosis or death. Data on survival and renal function were analyzed with respect to age, sex, ANCA specificity, renal function, C-reactive protein, comorbidities, and Birmingham Vasculitis ActivityScore at diagnosis as well as treatment during the first month. Results Median follow-up was 730 days (interquartile range, 244-730). Overall 1-year survival was 71.5% and 2-year survival was 64.6%. Older age; higher creatinine, and lowe

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FE - Ostatní obory vnitřního lékařství

OECD FORD obor

—

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2015

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Clinical Journal of the American Society of Nephrology

ISSN

1555-9041

e-ISSN

—

Svazek periodika

10

Číslo periodika v rámci svazku

7

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

8

Strana od-do

1128-1135

Kód UT WoS článku

000357754200006

EID výsledku v databázi Scopus

2-s2.0-84936868304